Onyx Bridge Wealth Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Sell
48,247
-894
-2% -$23.4K 0.1% 141
2026
Q1
$1.38M Buy
49,141
+1,282
+3% +$34.1K 0.15% 123
2025
Q4
$1.19M Buy
47,859
+1,336
+3% +$33.7K 0.13% 128
2025
Q3
$1.19M Buy
46,523
+6,614
+17% +$163K 0.13% 127
2025
Q2
$967K Buy
39,909
+7,813
+24% +$182K 0.13% 125
2025
Q1
$813K Sell
32,096
-1,118
-3% -$29.3K 0.12% 116
2024
Q4
$881K Buy
33,214
+2,290
+7% +$62.1K 0.13% 109
2024
Q3
$895K Buy
30,924
+5,802
+23% +$169K 0.13% 110
2024
Q2
$703K Buy
25,122
+484
+2% +$13.3K 0.12% 120
2024
Q1
$626K Buy
24,638
+5,596
+29% +$155K 0.11% 126
2023
Q4
$548K Buy
19,042
+1,841
+11% +$55.7K 0.11% 123
2023
Q3
$571K Buy
17,201
+1,852
+12% +$65.5K 0.13% 122
2023
Q2
$563K Buy
15,349
+5,029
+49% +$196K 0.13% 115
2023
Q1
$421K Buy
10,320
+54
+0.5% +$2.33K 0.17% 98
2022
Q4
$523K Sell
10,266
-12
-0.1% -$575 0.21% 74
2022
Q3
$432K Buy
10,278
+226
+2% +$11K 0.2% 85
2022
Q2
$515K Sell
10,052
-3,684
-27% -$188K 0.23% 65
2022
Q1
$683K Buy
13,736
+1,453
+12% +$75.4K 0.26% 45
2021
Q4
$696K Buy
12,283
+323
+3% +$16K 0.23% 53
2021
Q3
$494K Buy
11,960
+6,561
+122% +$291K 0.19% 68
2021
Q2
$218K Sell
5,399
-2,360
-30% -$91.8K 0.09% 107
2021
Q1
$281K Buy
+7,759
New +$275K 0.14% 74

Other funds holding PFE

Onyx Bridge Wealth Group's PFE Position: Q2 2026 in Review

Onyx Bridge Wealth Group reduced its Pfizer (PFE) stake by 1.8% in Q2 2026, selling an estimated $23.4K and leaving 48,247 shares worth $1.16M. The position accounts for 0.1% of the portfolio, ranked #141.

Onyx Bridge Wealth Group first reported a position in PFE in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.38M in Q1 2026. 991 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Onyx Bridge Wealth Group held 48,247 shares of Pfizer worth $1.16M as of Q2 2026.
  • Onyx Bridge Wealth Group sold 894 Pfizer shares in Q2 2026, an estimated $23.4K.
  • Pfizer made up 0.1% of Onyx Bridge Wealth Group's portfolio in Q2 2026, its #141 holding.
  • Onyx Bridge Wealth Group first reported a position in Pfizer in Q1 2021 and has held it in 22 quarters since.
  • Onyx Bridge Wealth Group's Pfizer position peaked at $1.38M in Q1 2026.
  • 991 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Onyx Bridge Wealth Group's 13F filing for Q2 2026, filed 23 Jul 2026.